Aetna’s most recent trend suggests a bullish bias. One trading opportunity on Aetna is a Bull Put Spread using a strike $177.50 short put and a strike $172.50 long put offers a potential 11.36% return on risk over the next 8 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $177.50 by expiration. The full premium credit of $0.51 would be kept by the premium seller. The risk of $4.49 would be incurred if the stock dropped below the $172.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Aetna is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Aetna is bullish.
The RSI indicator is at 64.78 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Aetna
CVS Boss Larry Merlo’s Path From Corner Pharmacy to C-Suite
Wed, 06 Dec 2017 01:53:49 +0000
The architect of the year’s biggest and arguably most surprising health-care deal is a former pharmacist from rural Pennsylvania who won over Wall Street with a reboot of CVS Health Corp.
Aetna’s Outgoing CEO Set to Reap About $500 Million if CVS Deal Closes
Wed, 06 Dec 2017 01:52:33 +0000
Aetna Chief Executive Mark T. Bertolini is set to pocket roughly half a billion dollars when he leaves his company if it successfully merges with CVS Health.
CVS’s Aetna Takeover Comes With a $2.1 Billion Termination Fee
Tue, 05 Dec 2017 23:13:25 +0000
CVS Health Corp. could owe Aetna Inc. $2.1 billion if the drugstore chain’s acquisition of the health insurer fails, according to a merger agreement filed Tuesday.
CVS-Aetna Deal: What's Hot, What's Not
Tue, 05 Dec 2017 22:00:10 +0000
CVS Health (CVS) and Aetna consolidation to add a new dimension to healthcare landscape. However, critics believe the gain will be short-lived for the healthcare society.
Rep. Pallone calls for hearing on CVS-Aetna deal
Tue, 05 Dec 2017 21:46:00 +0000
CNBC's Seema Mody reports that Rep. Frank Pallone (D-NJ) is calling for a hearing on the CVS-Aetna merger deal.
Also on Market Tamer…
Follow Us on Facebook